MERRIMACK PHARMACEUTICALS INC 4
4 · MERRIMACK PHARMACEUTICALS INC · Filed Jun 15, 2017
Insider Transaction Report
Form 4
Santillana Sergio L.
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2017-06-13+450,000→ 450,000 totalExercise: $1.35Exp: 2027-06-12→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]This option vests as to 1/6th of the total number of shares granted on 12/12/17 and an additional 1/12th of the total number of shares granted at the end of each successive three month period thereafter until 6/12/20.